Attendance is free but space is limited and registration is required. Register now.




8:45 a.m.

Registration and Breakfast

9:30 a.m.


Djordje Atanackovic, MD

9:35 a.m.

BCMA-Specific CAR T Cells for Multiple Myeloma

Adam Cohen, MD
Abramson Cancer Center, University of Pennsylvania

10:05 a.m.

Treatments for Newly Diagnosed Multiple Myeloma

Mary Steinbach, DNP, APRN

10:25 a.m.

Engineering Immunotherapies for the Treatment of Multiple Myeloma

Tim Luetkens, MD

10:45 a.m.


11:05 a.m.

Relapsed and Refractory Multiple Myeloma-
Current and Future Tools in the Therapeutic Arsenal

Douglas Sborov, MD, MS

11:25 a.m.

Radiation Therapy in the Multidisciplinary Care of Multiple Myeloma Patients

Randa Tao, MD

11:45 a.m.

Allogeneic Stem Cell Transplantation in Multiple Myeloma

Axel Zander, MD

12:05 p.m.


12:50 p.m.

Clinical Update on BCMA Targeted CAR T cells in Relapsed and/or Refractory Myeloma, bb2121 Phase 1 First in Human Update

Yi Lin, MD, PhD
Mayo Clinic, Rochester

1:20 p.m.

Neuromuscular Complications of Chemotherapy Lessons from the Clinic

Kelsey Juster-Switlyk, MD

1:40 p.m.

Renal disease in Multiple Myeloma and Monoclonal Gammopathy

Josephine D. Abraham, MD

2 p.m.

Introduction to Resources for Goals of Care Conversations About Life-Sustaining Treatments

Shaida Talebreza, MD, AGSF, FAAHPM, HMDC

2:20 p.m.


2:40 p.m. 

Evolving Imaging Considerations for Diagnosis and Therapy

Carl Christensen, MD

3 p.m.

Depression in Cancer Patients

Paul Thielking, MD

3:20 p.m.

The Therapeutic Value of Integrative Medicine for Patients and their Families

Annie Budhathoki, DAOM, LA

3:40 p.m.


Djordje Atanackovic, MD